Cologuard has a false positive rate of 13%.
I read somewhere (still hunting the source down) that if you take a screening test, and later need a colonoscopy, the colonoscopy will be considered diagnostic, and no longer covered by insurance. So if you take a Cologuard test, that would be your screening test. If you test falsely positive, the colonoscopy will be diagnostic, and will not be covered by insurance.
A colonoscopy is quite inexpensive in America especially if you do it without anesthesia as Europeans do. I have done it without anesthesia every time, and it is only mildly unpleasant.
FWIW
Your posting was NOT flagged by me.
RapAdmin could easily verify that.
That’s alright, just don’t post comments with only quotes anymore, as it’s just annoying to the people you are sending them to. And it doesn’t even make sense if you want to be taken seriously.
OK guys - Joseph was correct in that he didn’t flag your post @AnUser
Please - and this applies to everyone - no more off-topic quotes in the forum. I will delete them.
Please lets focus on the topic at hand.
Reishi extract has been shown in a human clinical trial to suppress the development of precancerous lesions in the colon. It prevented development and reduced the size of existing adenomas.
It has also been shown to extend lifespan in mice. There is a recent thread here:
Personally with a family history of colon cancer I do prevention with menbendazole or fenbendazole twice a week. Nac paired with glycine too. Probiotics especially s. boullardii and cervasie for added benefit.
And you should/must consume flax seeds daily.
Modified Citrus Pectin (Pectasol) is a no brainer. It works for most cancer. Sister in law had colon cancer and she credits it for saving her life.
Can you tell me more please, as regards to what you are using and at dose. My mum died with a diffuse colon cancer.
The colonoscopy is nothing. The prep is murder 
Hello, I am a colon cancer survivor in remission now for 7 years. I still use non traditional treatments to prevent future cancers. Low dose Naltrexone, SAM shots which are sequenced amino acid modulation and weekly IV therapy. Glutathione/Phosphatidyl IV push. Recently I came across Fenbendazole which is basically an animal de-wormer but taken 444mg 1x/day has been miraculously curing inoperable cancers. Does anyone have experience with this? I know there is a FDA drug called Dostarlimab which has had 100% success but cost $11,000/shot unless you fly to India. I am still on Rapamycin now for 9 months. I am doing great.
Can you give a reference to this please, thanks
I have some experience with this. Typically I rotate fenbendazole out with menbendazole and albendazole. Menbendazole and albendazole crosses the blood brain barrier. Again the dosages are pulsed out twice or 3 times a week at 500 mg fen, 200 mg men and once a month 1200 mg alben. Nac with glycine is a must. Also use a myriad of supplements with it. Should be noted that fenbendazole needs to be paired with vit a (retinol) d3, methylated b complex, vit e and k2 in order for higher anti neoplasm potency. Liposomal vit c and glutathione too with clinical strength probiotics thrown in for good measure.
Red meat and processed meat is associated with colon cancer.
Sounds amazing, but unfortunately the 100% cure rate is only for patients with a specific mutation present in only 4% of cancer patients.
But if you are one of those 4%, it is amazing.
They are trying to push it up to 10%. I wish them luck.
HT Lustgarten:
Background: Following a vegetarian diet has become increasingly popular and some evidence suggests that being vegetarian may be associated with a lower risk of cancer overall. However, for specific cancer sites, the evidence is limited. Our aim was to assess the associations of vegetarian and non-vegetarian diets with risks of all cancer, colorectal cancer, postmenopausal breast cancer, and prostate cancer and to explore the role of potential mediators between these associations.
Methods: We conducted a prospective analysis of 472,377 UK Biobank participants who were free from cancer at recruitment. Participants were categorised into regular meat-eaters (n = 247,571), low meat-eaters (n = 205,385), fish-eaters (n = 10,696), and vegetarians (n = 8685) based on dietary questions completed at recruitment. Multivariable-adjusted Cox regressions were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for all cancer incidence and separate cancer sites across diet groups.
Results: After an average follow-up of 11.4 years, 54,961 incident cancers were identified, including 5882 colorectal, 7537 postmenopausal breast, and 9501 prostate cancers. Compared with regular meat-eaters, being a low meat-eater, fish-eater, or vegetarian were all associated with a lower risk of all cancer (HR: 0.98, 95% CI: 0.96-1.00; 0.90, 0.84-0.96; 0.86, 0.80-0.93, respectively). Being a low meat-eater was associated with a lower risk of colorectal cancer in comparison to regular meat-eaters (0.91, 0.86-0.96); however, there was heterogeneity in this association by sex (p = 0.007), with an inverse association across diet groups in men, but not in women. Vegetarian postmenopausal women had a lower risk of breast cancer (0.82, 0.68-0.99), which was attenuated and non-significant after adjusting for body mass index (BMI; 0.87, 0.72-1.05); in mediation analyses, BMI was found to possibly mediate the observed association. In men, being a fish-eater or a vegetarian was associated with a lower risk of prostate cancer (0.80, 0.65-0.99 and 0.69, 0.54-0.89, respectively).
These women know all too painfully well that something strange is happening in the United States in the long war on cancer. Although progress has been substantial in lowering the overall death rate from cancer, deaths due to some types of cancer have increased among people younger than 50.
Colorectal cancer is one of the drivers of this trend. In the past three decades, incidence of the disease has risen significantly among people younger than 50, many of whom have no obvious risk factors, such as having a genetic predisposition. No one knows why.
https://www.washingtonpost.com/health/2023/12/21/colon-cancer-increasing-young-adults/
Full article: Colon cancer is rising in young Americans. It’s not clear why. - The Washington Post
“Colorectal cancer is no longer considered just a disease of the elderly population,” said lead researcher Islam Mohamed, MD, an internal medicine resident physician at the University of Missouri-Kansas City. “It’s important that the public is aware of signs and symptoms of colorectal cancer.”
Risk factors include a family history of inflammatory bowel disease or colorectal cancer. Modifiable risk factors include obesity, tobacco use, alcohol consumption, and dietary habits such as low fiber intake, consumption of processed meats or sugar-sweetened beverages, and a high-fat diet. A sedentary lifestyle, the presence of bacteria that tend to cause tumors, antibiotic usage, and dietary additives are potential, but not firmly established, contributors to colorectal cancer risk.
